Deutsche Bank
PPH icon

Deutsche Bank’s VanEck Pharmaceutical ETF PPH Stock Holding History

Deutsche Bank’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,009
Closed -$64K – 5754
2014
Q4 		$64K Buy
1,009
+9
+0.9% +$573 ﹤0.01% 4993
2014
Q3 		$63K Buy
1,000
+500
+100% +$31K ﹤0.01% 4738
2014
Q2 		$31K Sell
500
-1,100
-69% -$65.4K ﹤0.01% 5144
2014
Q1 		$93K Buy
1,600
+820
+105% +$46.4K ﹤0.01% 4269
2013
Q4 		$41K Sell
780
-780
-50% -$39.5K ﹤0.01% 4437
2013
Q3 		$74K Buy
1,560
+980
+169% +$46.5K ﹤0.01% 4539
2013
Q2 		$26K Buy
+580
New +$26.8K ﹤0.01% 4706

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MIM
Macroview Investment Management Bethesda, Maryland $144M AUM 19.29% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
AHS
Aspiriant Holdings S3 Los Angeles, California $233M AUM 3.13% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Deutsche Bank's PPH Position: Q1 2015 in Review

Deutsche Bank sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2015, closing a stake of 1,009 shares — an estimated $64K sold.

Deutsche Bank first reported a position in PPH in Q2 2013 and held it in 7 quarters. The position peaked at $93K in Q1 2014. 52 funds tracked by Wall St. Rank hold PPH as of Q1 2015.

  • Deutsche Bank reported no remaining VanEck Pharmaceutical ETF position as of Q1 2015 after selling out during the quarter.
  • Deutsche Bank sold 1,009 VanEck Pharmaceutical ETF shares in Q1 2015, an estimated $64K.
  • Deutsche Bank first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and held it in 7 quarters.
  • Deutsche Bank's VanEck Pharmaceutical ETF position peaked at $93K in Q1 2014.
  • 52 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2015.

Based on Deutsche Bank's 13F filing for Q1 2015, filed 15 May 2015.